Invuity Inc (IVTY) Receives Average Recommendation of “Hold” from Brokerages

Shares of Invuity Inc (NASDAQ:IVTY) have earned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat reports. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $4.25.

Several research firms recently issued reports on IVTY. Leerink Swann cut Invuity from an “outperform” rating to a “market perform” rating in a research report on Wednesday, September 12th. ValuEngine raised Invuity from a “sell” rating to a “hold” rating in a report on Wednesday, September 12th. Stifel Nicolaus cut Invuity from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Piper Jaffray Companies cut Invuity from an “overweight” rating to a “neutral” rating in a report on Tuesday, September 11th. Finally, Northland Securities cut Invuity from an “outperform” rating to a “market perform” rating in a report on Monday, September 17th.

IVTY stock opened at $7.39 on Friday. Invuity has a 12-month low of $2.35 and a 12-month high of $9.55.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp bought a new position in shares of Invuity during the 3rd quarter valued at $112,000. Fondren Management LP bought a new position in shares of Invuity during the 2nd quarter valued at $168,000. Northern Trust Corp lifted its holdings in shares of Invuity by 32.4% during the 2nd quarter. Northern Trust Corp now owns 45,244 shares of the medical instruments supplier’s stock valued at $176,000 after buying an additional 11,073 shares during the period. Spark Investment Management LLC lifted its holdings in shares of Invuity by 138.2% during the 2nd quarter. Spark Investment Management LLC now owns 45,500 shares of the medical instruments supplier’s stock valued at $177,000 after buying an additional 26,400 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Invuity by 5,196.9% during the 1st quarter. JPMorgan Chase & Co. now owns 47,672 shares of the medical instruments supplier’s stock valued at $184,000 after buying an additional 46,772 shares during the period. 55.34% of the stock is currently owned by hedge funds and other institutional investors.

About Invuity

Invuity, Inc, a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities.

Featured Story: How do candlesticks reflect price movement?

Analyst Recommendations for Invuity (NASDAQ:IVTY)

Receive News & Ratings for Invuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply